4 quarters tracked · Beat rate 100% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $1.51 | $1.60 | +5.8% | Beat |
| Q4 2025 | 2025-12-31 | $1.31 | $1.46 | +11.3% | Beat |
| Q3 2025 | 2025-09-30 | $1.21 | $1.23 | +1.9% | Beat |
| Q2 2025 | 2025-06-30 | $1.22 | $1.40 | +14.6% | Beat |
Earnings Beat Rate
Encompass Health has beaten analyst EPS estimates in 4 of 4 tracked quarters (100% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →